<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00002068</url>
  </required_header>
  <id_info>
    <org_study_id>012H</org_study_id>
    <secondary_id>056-159B</secondary_id>
    <nct_id>NCT00002068</nct_id>
  </id_info>
  <brief_title>A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis</brief_title>
  <official_title>A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NIH AIDS Clinical Trials Information Service</source>
  <brief_summary>
    <textblock>
      To compare the safety and effectiveness of fluconazole and amphotericin B, alone or in
      combination with flucytosine, as treatment for acute cryptococcal meningitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <condition>Meningitis, Cryptococcal</condition>
  <condition>HIV Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluconazole</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amphotericin B</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        Concurrent Medication:

        Allowed:

          -  Immunosuppressant therapy.

          -  Antiviral therapy such as zidovudine.

          -  Prophylaxis for Pneumocystis carinii pneumonia.

        Concurrent Treatment:

        Allowed:

          -  Radiation therapy for mucocutaneous Kaposi's sarcoma.

        Written informed consent must be obtained for each patient, either from the patient himself
        or from the patient's legal guardian.

          -  No prior systemic antifungal therapy for cryptococcosis.

          -  Relapse after prior therapy.

          -  Success of prior therapy must have been documented by negative cerebrospinal fluid
             (CSF) culture at the end of therapy. Following prior therapy, such patients may not
             have received more than 1 mg/kg/wk amphotericin B in the 4 weeks before entry into
             study.

        Prior Medication:

        Allowed:

          -  Immunosuppressant therapy.

          -  Antiviral therapy such as zidovudine.

          -  Prophylaxis for Pneumocystis carinii pneumonia.

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following are excluded:

          -  Evidence of acute or chronic meningitis based upon any etiology other than
             cryptococcosis.

          -  History of allergy to or intolerance of imidazoles, azoles, or amphotericin B.

          -  Moderate or severe liver disease.

          -  Comatose.

          -  Unlikely to survive more than 2 weeks.

        Concurrent Medication:

        Excluded within 4 weeks of study entry:

          -  Greater than 1 mg/kg/wk amphotericin B.

          -  Coumadin-type anticoagulants.

          -  Oral hypoglycemics.

          -  Barbiturates.

          -  Phenytoin.

          -  Immunostimulants.

          -  Investigational drugs or approved (licensed) drugs for investigational indications.

        Concurrent Treatment:

        Excluded:

          -  Lymphocyte replacement.

        Patients with the following are excluded:

          -  Evidence of acute or chronic meningitis based upon any etiology other than
             cryptococcosis.

          -  History of allergy to or intolerance of imidazoles, azoles, or amphotericin B.

          -  Moderate or severe liver disease.

          -  Comatose.

          -  Unlikely to survive more than 2 weeks.

        Prior Medication:

        Excluded within 4 weeks of study entry:

          -  Greater than 1 mg/kg/wk amphotericin B.

          -  Coumadin-type anticoagulants.

          -  Oral hypoglycemics.

          -  Barbiturates.

          -  Phenytoin.

          -  Immunostimulants.

          -  Investigational drugs or approved (licensed) drugs for investigational indications.

        Prior Treatment:

        Excluded:

          -  Lymphocyte replacement.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Davies Med Ctr</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Hosp / Med Ctr of Delaware</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19899</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ of Maryland / Inst of Human Virology</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>212011192</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hosp</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harlem AIDS Treatment Group / Harlem Hosp Ctr</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ of Tennessee</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Michael's Hosp</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 1990</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 1999</study_first_submitted>
  <study_first_submitted_qc>August 30, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2001</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>AIDS-Related Opportunistic Infections</keyword>
  <keyword>Meningitis</keyword>
  <keyword>Cryptococcosis</keyword>
  <keyword>Drug Therapy, Combination</keyword>
  <keyword>Fluconazole</keyword>
  <keyword>Flucytosine</keyword>
  <keyword>Acquired Immunodeficiency Syndrome</keyword>
  <keyword>Amphotericin B</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Meningitis, Cryptococcal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluconazole</mesh_term>
    <mesh_term>Amphotericin B</mesh_term>
    <mesh_term>Liposomal amphotericin B</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

